» Articles » PMID: 23219967

Increased Gait Variability in Mice with Small Cerebellar Cortex Lesions and Normal Rotarod Performance

Overview
Journal Behav Brain Res
Date 2012 Dec 11
PMID 23219967
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The physiological and pathophysiological role of the cerebellum in neuromotor performance and gait is a prominent research topic in contemporary brain research. However, it has proven difficult to measure subtle neuromotor changes and cerebellar dysfunction in laboratory rodents with some of the common behavioural assays. Rotarod assays and gait analyses have been used extensively as indicators of neuromotor performance, and more specifically, cerebellar function. Standard rotarod procedures fail to reveal subtle motor alterations, whereas automated gait analysis could be more sensitive in this respect. In the present study, we compared detailed treadmill gait analysis to the standard accelerating rotarod assay in its ability to reveal neuromotor alterations in mice with small bilateral lesions in the cerebellar cortex. This small lesion model showed no readily observable signs of ataxia or abnormal activity. In the rotarod test, cerebellar-lesioned mice performed at the level of control animals, and basic gait parameters were not altered. However, cerebellar-lesioned mice did show increased front base-width and hind stride length variability, as well as increased stride length incongruity between different paws. We conclude that small cerebellar lesions lead to increased gait variability as it does in humans with cerebellar dysfunction. Treadmill gait analysis is better suited than accelerating rotarod assays to measure such subtle neuromotor defects.

Citing Articles

Lactobacillus fermentum ATCC 9338 Supplementation Prevents Depressive-Like Behaviors Through Glucocorticoid Receptor and N-Methyl-D-aspartate2b in Chronic Unpredictable Mild Stress Mouse Model.

Tiwari S, Paramanik V Mol Neurobiol. 2025; .

PMID: 39956887 DOI: 10.1007/s12035-025-04738-3.


Targeted therapy improves cellular dysfunction, ataxia, and seizure susceptibility in a model of a progressive myoclonus epilepsy.

Feng H, Clatot J, Kaneko K, Flores-Mendez M, Wengert E, Koutcher C Cell Rep Med. 2024; 5(2):101389.

PMID: 38266642 PMC: 10897515. DOI: 10.1016/j.xcrm.2023.101389.


Deficits Associated With Loss of STIM1 in Purkinje Neurons Including Motor Coordination Can Be Rescued by Loss of Septin 7.

Dhanya S, Hasan G Front Cell Dev Biol. 2022; 9:794807.

PMID: 34993201 PMC: 8724567. DOI: 10.3389/fcell.2021.794807.


Protective effects on acute hypoxic-ischemic brain damage in mfat-1 transgenic mice by alleviating neuroinflammation.

Geng X, Wang M, Leng Y, Li L, Yang H, Dai Y J Biomed Res. 2021; 35(6):474-490.

PMID: 34744086 PMC: 8637658. DOI: 10.7555/JBR.35.20210107.


Shared and specific signatures of locomotor ataxia in mutant mice.

Machado A, Marques H, Duarte D, Darmohray D, Carey M Elife. 2020; 9.

PMID: 32718435 PMC: 7386913. DOI: 10.7554/eLife.55356.